利用者成果(英) |
21908
Ito M, Koido S, Iwamoto T, Morimoto S, Fujiki F, Sugiyama H, Matsumoto S, Effenberger C, Kiyotani K, Shiba K.
Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors.
PLoS One
2024
19(8):e0308330
PubMed ID: 39116074
DOI: 10.1371/journal.pone.0308330
|
19593
Kreienbühl J, Changkhong S, Orlowski V, Kirschner MB, Opitz I, Meerang M.
Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma
Int J Mol Sci
2023
24(17):13410
PubMed ID: 37686215
DOI: 10.3390/ijms241713410
|
19685
Sakabe N, Maruyama S, Ito C, Shimoyama Y, Komene T, Oboshi W, Sato S, Sudo K, Ikeda K.
Immunocytochemical Reactivity Comparison between Formalin-Fixed and Liquid-Based Cytology-Fixed Specimens
Acta Cytol
2023
67(1):38-45
PubMed ID: 36228592
DOI: 10.1159/000526131
|
19753
Endo I, Amatya VJ, Kushitani K, Nakagiri T, Aoe K, Takeshima Y.
Long Non-coding RNA LINC00152 Requires EZH2 to Promote Mesothelioma Cell Proliferation, Migration, and Invasion
Anticancer Res
2023
43(12):5367-5376
PubMed ID: 38030172
DOI: 10.21873/anticanres.16740
|
19758
Endo I, Amatya VJ, Kushitani K, Nakagiri T, Aoe K, Takeshima Y.
miR-142-3p Suppresses Invasion and Adhesion of Mesothelioma Cells by Downregulating ITGAV
Pathobiology
2023
90(4):270-280
PubMed ID: 36724751
DOI: 10.1159/000528670
|
19954
Okamura K, Inoue H, Tanaka K, Ikematsu Y, Furukawa R, Ota K, Yoneshima Y, Iwama E, Okamoto I.
Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma
Cancer Sci
2023
114(3):1095-1107
PubMed ID: 36369966
DOI: 10.1111/cas.15645
|
21058
Yang H, Gao Y, Xu D, Xu K, Liang SQ, Yang Z, Scherz A, Hall SRR, Forster S, Berezowska S, Yao F, Ochsenbein AF, Marti TM, Kocher GJ, Schmid RA, Dorn P, Peng RW.
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma.
Cell Death Discov
2023
9(1):55
PubMed ID: 36765038
DOI: 10.1038/s41420-023-01307-2
|
21089
Sakura K, Sasai M, Funaki S, Shintani Y, Okumura M, Kaneda Y.
Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study.
Cancers (Basel)
2023
15(3)
PubMed ID: 36765886
DOI: 10.3390/cancers15030929
|
21383
Endo I, Amatya VJ, Kushitani K, Kambara T, Nakagiri T, Aoe K, Takeshima Y.
FOXM1 Promotes Mesothelioma Cell Migration and Invasion via Activation of SMAD Signaling.
Anticancer Res
2023
43(9):3961-3968
PubMed ID: 37648326
DOI: 10.21873/anticanres.16583
|
21461
Nakagiri T, Amatya VJ, Kushitani K, Kambara T, Aoe K, Endo I, Miyata Y, Okada M, Takeshima Y.
SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma.
Am J Surg Pathol
2023
PubMed ID: 37899530
DOI: 10.1097/PAS.0000000000002147
|
17557
Tomita R, Nishijo N, Hayama T, Fujioka T.
Discrimination of Malignant Pleural Mesothelioma Cell Lines Using Amino Acid Metabolomics with HPLC
Biol Pharm Bull
2022
45(6):724-729.
PubMed ID: 35650101
DOI: 10.1248/bpb.b21-00972
|
17590
Hagiyama M, Mimae T, Wada A, Takeuchi F, Yoneshige A, Inoue T, Kotoku N, Hamada H, Sekido Y, Okada M, Ito A.
Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma
Front Cell Dev Biol
2022
10:945007
PubMed ID: 35903548
DOI: 10.3389/fcell.2022.945007
|
17671
Endo I, Amatya VJ, Kushitani K, Kambara T, Nakagiri T, Fujii Y, Takeshima Y.
Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1
Front Oncol
2022
11:795467
PubMed ID: 35127504
DOI: 10.3389/fonc.2021.795467
|
20462
Fujii Y, Amatya VJ, Kushitani K, Suzuki R, Kai Y, Kambara T, Takeshima Y.
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1.
Oncol Rep
2022
47(2)
PubMed ID: 34859258
DOI: 10.3892/or.2021.8238
|
20801
Hasegawa M, Hanamatsu Y, Saigo C, Kito Y, Takeuchi T.
Tumor suppressor effect of an antibody on xenotransplanted sarcomatoid mesothelioma cells.
Thorac Cancer
2022
PubMed ID: 35916358
DOI: 10.1111/1759-7714.14591
|
20093
Yang H, Hall SRR, Sun B, Zhao L, Gao Y, Schmid RA, Tan ST, Peng RW, Yao F.
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.
Cancers (Basel)
2021
13(7)
PubMed ID: 33805359
DOI: 10.3390/cancers13071561
|
20510
Takasaka M, Kobayashi S, Usui Y, Haniu H, Tsuruoka S, Aoki K, Saito N.
Biokinetic Evaluation of Contrast Media Loaded Carbon Nanotubes Using a Radiographic Device.
Toxics
2021
9(12)
PubMed ID: 34941765
DOI: 10.3390/toxics9120331
|
20560
Abukar A, Wipplinger M, Hariharan A, Sun S, Ronner M, Sculco M, Okonska A, Kresoja-Rakic J, Rehrauer H, Qi W, Beusechem VWV, Felley-Bosco E.
Double-Stranded RNA Structural Elements Holding the Key to Translational Regulation in Cancer: The Case of Editing in RNA-Binding Motif Protein 8A.
Cells
2021
10(12)
PubMed ID: 34944051
DOI: 10.3390/cells10123543
|
16120
Kanayama M, Oyama R, Mori M, Taira A, Shinohara S, Kuwata T, Takenaka M, Yoneda K, Kuroda K, Ohnaga T, Kato Y, Tanaka F.
Novel circulating tumor cell-detection chip combining conventional podoplanin and EGFR antibodies for all histological malignant pleural mesothelioma
Oncol Lett
2021
22(1):522
PubMed ID: 34025789
DOI: 10.3892/ol.2021.12783
|
6938
Okonska A, Bühler S, Rao V, Ronner M, Blijlevens M, van der Meulen-Muileman IH, de Menezes RX, Wipplinger M, Oehl K, Smit EF, Weder W, Stahel RA, Penengo L, van Beusechem VW, Felley-Bosco E.
Functional genomic screen in mesothelioma reveals that loss of function of BRCA1-associated-protein-1 induces chemoresistance to ribonucleotide reductase inhibition.
Mol Cancer Ther
2020
19(2):552-563
PubMed ID: 31619462
DOI: 10.1158/1535-7163.MCT-19-0356
|
12125
Fujii T, Itami H, Uchiyama T, Morita K, Nakai T, Hatakeyama K, Sugimoto A, Shimada K, Tsuji S, Ohbayashi C.
HEG1-responsive microRNA-23b regulates cell proliferation in malignant mesothelioma cells.
Biochem. Biophys. Res. Commun.
2020
PubMed ID: 32284171
DOI: 10.1016/j.bbrc.2020.03.172
|
13171
Yang H, Xu D, Yang Z, Yao F, Zhao H, Schmid RA, Peng RW.
Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma.
Cancers (Basel)
2020
PubMed ID: 32824422
DOI: 10.3390/cancers12082310
|
13236
Jotatsu T, Izumi H, Morimoto Y, Yatera K.
Selection of microRNAs in extracellular vesicles for diagnosis of malignant pleural mesothelioma by in vitro analysis.
Oncol Rep
2020
PubMed ID: 33000251
DOI: 10.3892/or.2020.7778
|
13275
Sakai K, Nishiuchi T, Tange S, Suzuki Y, Yano S, Terashima M, Suzuki T, Matsumoto K.
Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion.
Sci Rep
2020
PubMed ID: 33028834
DOI: 10.1038/s41598-020-72448-y
|
13551
Han B, Lee-Okada HC, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T.
Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells
FEBS Open Bio
2020
10(11):2375-2387
PubMed ID: 32961616
DOI: 10.1002/2211-5463.12985
|
13608
Kuwata T, Yoneda K, Mori M, Kanayama M, Kuroda K, Kaneko MK, Kato Y, Tanaka F.
Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the "Universal" CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2
Cells
2020
9(4):888
PubMed ID: 32260559
DOI: 10.3390/cells9040888
|
14504
Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Fujii Y, Takeshima Y.
Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin
Oncol Lett
2020
19(6):4161-4168
PubMed ID: 32382354
DOI: 10.3892/ol.2020.11504
|
10679
Yoneda K, Chikaishi Y, Kuwata T, Ohnaga T, Tanaka F.
Capture of mesothelioma cells with 'universal' CTC-chip.
Oncol Lett
2018
15:2635-2640
PubMed ID: 29434985
DOI: 10.3892/ol.2017.7619
|
11150
Ohno Y, Shingyoku S, Miyake S, Tanaka A, Fudesaka S, Shimizu Y, Yoshifuji A, Yamawaki Y, Yoshida S, Tanaka S, Sakura K, Tanaka T.
Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.
Oncogene
2018
37(49):6357-6367
PubMed ID: 30061637
DOI: 10.1038/s41388-018-0405-y
|
11207
Okamoto T, Yamazaki H, Hatano R, Yamada T, Kaneko Y, Xu CW, Dang NH, Ohnuma K, Morimoto C.
Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.
Biochem. Biophys. Res. Commun.
2018
PubMed ID: 30197002
DOI: 10.1016/j.bbrc.2018.08.193
|
11107
Xu D, Liang SQ, Yang H, Luthi U, Riether C, Berezowska S, Marti TM, Hall SRR, Bruggmann R, Kocher GJ, Schmid RA, Peng RW.
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
Br. J. Cancer
2018
119(1):65-75
PubMed ID: 29921948
DOI: 10.1038/s41416-018-0145-3
|
11217
Matsuura R, Kaji H, Tomioka A, Sato T, Narimatsu H, Moriwaki Y, Misawa H, Imai K, Tsuji S.
Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1.
Sci Rep
2018
PubMed ID: 30250045
DOI: 10.1038/s41598-018-32534-8
|
4469
Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y.
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma.
Front Oncol
2018
8:446
PubMed ID: 30406026
DOI: 10.3389/fonc.2018.00446
|
7034
Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, Yokose T, Kameda Y, Hayashi H, Morohoshi T, Tsuura Y, Yusa T, Sato T, Togayachi A, Narimatsu H, Nagasaki T, Nakamoto K, Moriwaki Y, Misawa H, Hiroshima K, Miyagi Y, Imai K.
HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma.
Sci Rep
2017
7:45768
PubMed ID: 28361969
DOI: 10.1038/srep45768
|
14252
Maki T, Ikeda H, Kuroda A, Kyogoku N, Yamamura Y, Tabata Y, Abiko T, Tsuchikawa T, Hida Y, Shichinohe T, Tanaka E, Kaga K, Hatanaka K, Matsuno Y, Imai N, Hirano S.
Differential detection of cytoplasmic Wilms tumor 1 expression by immunohistochemistry, western blotting and mRNA quantification
Int J Oncol
2017
50(1):129-140.
PubMed ID: 27922671
DOI: 10.3892/ijo.2016.3786
|
14253
Satoh T, Tatsuta T, Sugawara S, Hara A, Hosono M.
Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma
Oncotarget
2017
8(26):42466-42477
PubMed ID: 28476017
DOI: 10.18632/oncotarget.17198
|
14487
Mawas AS, Amatya VJ, Suzuki R, Kushitani K, Mohi El-Din MM, Takeshima Y.
PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells
Int J Oncol
2017
50(3):1029-1034
PubMed ID: 28197633
DOI: 10.3892/ijo.2017.3863
|
9731
Mizutani N, Abe M, Matsuoka S, Kajino K, Wakiya M, Ohtsuji N, Hatano R, Morimoto C, Hino O.
Establishment of anti-mesothelioma monoclonal antibodies.
BMC Res Notes
2016
9:324
PubMed ID: 27342200
DOI: 10.1186/s13104-016-2128-x
|
12632
Amatya VJ, Mawas AS, Kushitani K, Mohi El-Din MM, Takeshima Y.
Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma
Int J Oncol
2016
48(4):1599-607
PubMed ID: 26820394
DOI: 10.3892/ijo.2016.3358
|
12672
Seki Y, Fujiwara Y, Kohno T, Takai E, Sunami K, Goto Y, Horinouchi H, Kanda S, Nokihara H, Watanabe S, Ichikawa H, Yamamoto N, Kuwano K, Ohe Y.
Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors
Oncologist
2016
21(2):156-64
PubMed ID: 26768482
DOI: 10.1634/theoncologist.2015-0288
|
12680
Kushitani K, Amatya VJ, Mawas AS, Miyata Y, Okada M, Takeshima Y.
Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia
Pathobiology
2016
83(1):33-40
PubMed ID: 26735863
DOI: 10.1159/000442092
|
12937
Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Iwasaki A, Okamoto T, Oda Y, Honda H, Nabeshima K.
BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests
Pathol Int
2016
66(10):563-570.
PubMed ID: 27614970
DOI: 10.1111/pin.12453
|
5349
Maruyama K, Haniu H, Saito N, Matsuda Y, Tsukahara T, Kobayashi S, Tanaka M, Aoki K, Takanashi S, Okamoto M, Kato H.
Endocytosis of Multiwalled Carbon Nanotubes in Bronchial Epithelial and Mesothelial Cells
Biomed Res Int
2015
2015:793186
PubMed ID: 26090445
DOI: 10.1155/2015/793186
|
19326
Haniu H, Saito N, Matsuda Y, Tsukahara T, Usui Y, Maruyama K, Takanashi S, Aoki K, Kobayashi S, Nomura H, Tanaka M, Okamoto M, Kato H.
Biological responses according to the shape and size of carbon nanotubes in BEAS-2B and MESO-1 cells
Int J Nanomedicine
2014
9:1979-90
PubMed ID: 24790438
DOI: 10.2147/IJN.S58661
|
3916
Okabe S, Okamoto T, Zhao CM, Chen D, Matsui H.
Acetic acid induces cell death: an in vitro study using normal rat gastric mucosal cell line and rat and human gastric cancer and mesothelioma cell lines.
J Gastroenterol Hepatol
2014
29 Suppl 4:65-9
PubMed ID: 25521736
DOI: 10.1111/jgh.12775
|
9149
Yoshikane Yamauchi, Yotaro Izumi, Keisuke Asakura, Yuichiro Hayashi, Hiroaki Nomori
Curcumin Induces Autophagy in ACC-MESO-1 Cells
Phytother Res
2012
26 (12), 1779-83
PubMed ID: 22388865
DOI: 10.1002/ptr.4645
|
7592
Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H.
Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses.
Int J Nanomedicine
2011
6:3295-307
PubMed ID: 22228997
DOI: 10.2147/IJN.S26573
|
7727
Asakura K, Izumi Y, Yamamoto M, Yamauchi Y, Kawai K, Serizawa A, Mizushima T, Ohmura M, Kawamura M, Wakui M, Adachi T, Nakamura M, Suematsu M, Nomori H.
The cytostatic effects of lovastatin on ACC-MESO-1 cells.
J. Surg. Res.
2011
170:e197-209
PubMed ID: 21816418
DOI: 10.1016/j.jss.2011.06.037
|
7784
Yamauchi Y, Izumi Y, Asakura K, Fukutomi T, Serizawa A, Kawai K, Wakui M, Suematsu M, Nomori H.
Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells.
Biochem. Biophys. Res. Commun.
2011
410:328-32
PubMed ID: 21672521
DOI: 10.1016/j.bbrc.2011.05.149
|
8088
Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Lee CM, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T.
Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma.
Int. J. Cancer
2011
129:1005-17
PubMed ID: 20949562
DOI: 10.1002/ijc.25716
|
8199
Hasegawa S, Koshikawa-Yano M, Saito S, Morokoshi Y, Furukawa T, Aoki I, Saga T.
Molecular imaging of mesothelioma by detection of manganese-superoxide dismutase activity using manganese-enhanced magnetic resonance imaging.
Int. J. Cancer
2011
128:2138-46
PubMed ID: 20617513
DOI: 10.1002/ijc.25547
|
19029
Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y.
LRRN4 and UPK3B are markers of primary mesothelial cells
PLoS One
2011
6(10):e25391
PubMed ID: 21984916
DOI: 10.1371/journal.pone.0025391
|
5413
Haniu H, Saito N, Matsuda Y, Kim YA, Park KC, Tsukahara T, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H.
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines.
Int J Nanomedicine
2011
6:3487-97
PubMed ID: 22267932
DOI: 10.2147/IJN.S26689
|
16309
Haniu H, Tsukahara T, Matsuda Y, Usui Y, Aoki K, Shimizu M, Ogihara N, Hara K, Takanashi S, Okamoto M, Ishigaki N, Nakamura K, Kato H, Saito N.
DJ-1 as a potential biomarker for the development of biocompatible multiwalled carbon nanotubes
Int J Nanomedicine
2011
6:2689-95
PubMed ID: 22114499
DOI: 10.2147/IJN.S25471
|
8186
Tsuji S, Tsuura Y, Morohoshi T, Shinohara T, Oshita F, Yamada K, Kameda Y, Ohtsu T, Nakamura Y, Miyagi Y.
Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
Br. J. Cancer
2010
103:517-23
PubMed ID: 20628387
DOI: 10.1038/sj.bjc.6605786
|
8379
Suzuki Y, Sakai K, Ueki J, Xu Q, Nakamura T, Shimada H, Nakamura T, Matsumoto K.
Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Int. J. Cancer
2010
127:1948-57
PubMed ID: 20104519
DOI: 10.1002/ijc.25197
|
18472
Nabeta M, Abe Y, Kagawa L, Haraguchi R, Kito K, Ueda N, Sugita A, Yokoyama M, Kusanagi Y, Ito M.
Identification of anti-α-enolase autoantibody as a novel serum marker for endometriosis
Proteomics Clin Appl
2009
3(10):1201-10
PubMed ID: 21136944
DOI: 10.1002/prca.200900055
|
19005
Hasegawa S, Koshikawa M, Takahashi I, Hachiya M, Furukawa T, Akashi M, Yoshida S, Saga T.
Alterations in manganese, copper, and zinc contents, and intracellular status of the metal-containing superoxide dismutase in human mesothelioma cells
J Trace Elem Med Biol
2008
22(3):248-55
PubMed ID: 18755401
DOI: 10.1016/j.jtemb.2008.05.001
|
13735
Ito A, Hagiyama M, Mimura T, Matsumoto M, Wakayama T, Iseki S, Yokozaki H, Okada M.
Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium
Lab Invest
2008
88(5):504-14
PubMed ID: 18332875
DOI: 10.1038/labinvest.2008.15
|
16153
Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, Saika T, Miyamura T, Chayama K, Nakamura Y, Wada H, Yamashita T, Morishima T, Old LJ, Nakayama E.
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity
Cancer Immun
2008
8:15.
PubMed ID: 19006261
|